Citigroup’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.5M | Sell |
322,064
-144,125
| -31% | -$18.1M | 0.02% | 499 |
|
|
2025
Q1 | $51.6M | Buy |
466,189
+301,009
| +182% | +$33.3M | 0.03% | 402 |
|
|
2024
Q4 | $22.5M | Sell |
165,180
-35,339
| -18% | -$4.82M | 0.01% | 603 |
|
|
2024
Q3 | $23.1M | Buy |
200,519
+84,230
| +72% | +$9.7M | 0.01% | 609 |
|
|
2024
Q2 | $16M | Sell |
116,289
-38,789
| -25% | -$5.34M | 0.01% | 712 |
|
|
2024
Q1 | $21.4M | Sell |
155,078
-16,855
| -10% | -$2.32M | 0.01% | 603 |
|
|
2023
Q4 | $22.7M | Sell |
171,933
-17,915
| -9% | -$2.36M | 0.02% | 538 |
|
|
2023
Q3 | $21.4M | Sell |
189,848
-19,273
| -9% | -$2.17M | 0.02% | 524 |
|
|
2023
Q2 | $19.7M | Sell |
209,121
-9,666
| -4% | -$912K | 0.01% | 588 |
|
|
2023
Q1 | $22.1M | Buy |
218,787
+80,811
| +59% | +$8.18M | 0.02% | 576 |
|
|
2022
Q4 | $16.5M | Buy |
137,976
+2,390
| +2% | +$285K | 0.01% | 628 |
|
|
2022
Q3 | $14.4M | Buy |
135,586
+40,677
| +43% | +$4.32M | 0.01% | 683 |
|
|
2022
Q2 | $9.25M | Buy |
94,909
+33,104
| +54% | +$3.23M | 0.01% | 861 |
|
|
2022
Q1 | $5.79M | Sell |
61,805
-44,956
| -42% | -$4.21M | ﹤0.01% | 1124 |
|
|
2021
Q4 | $9.09M | Buy |
106,761
+43,336
| +68% | +$3.69M | ﹤0.01% | 975 |
|
|
2021
Q3 | $6.08M | Sell |
63,425
-39,776
| -39% | -$3.82M | ﹤0.01% | 1189 |
|
|
2021
Q2 | $10M | Sell |
103,201
-6,576
| -6% | -$640K | 0.01% | 1050 |
|
|
2021
Q1 | $10.7M | Buy |
109,777
+2,753
| +3% | +$268K | 0.01% | 987 |
|
|
2020
Q4 | $10.3M | Buy |
107,024
+20,450
| +24% | +$1.96M | 0.01% | 945 |
|
|
2020
Q3 | $8.33M | Buy |
86,574
+4,947
| +6% | +$476K | 0.01% | 922 |
|
|
2020
Q2 | $9.96M | Buy |
81,627
+17,385
| +27% | +$2.12M | 0.01% | 777 |
|
|
2020
Q1 | $5.56M | Buy |
64,242
+22,141
| +53% | +$1.92M | 0.01% | 882 |
|
|
2019
Q4 | $4.53M | Sell |
42,101
-12,049
| -22% | -$1.3M | ﹤0.01% | 1166 |
|
|
2019
Q3 | $4.88M | Sell |
54,150
-29,154
| -35% | -$2.63M | ﹤0.01% | 1094 |
|
|
2019
Q2 | $7.03M | Buy |
83,304
+39,178
| +89% | +$3.31M | 0.01% | 967 |
|
|
2019
Q1 | $3.89M | Sell |
44,126
-24,723
| -36% | -$2.18M | ﹤0.01% | 1121 |
|
|
2018
Q4 | $4.92M | Buy |
68,849
+40,511
| +143% | +$2.89M | 0.01% | 1017 |
|
|
2018
Q3 | $3.48M | Sell |
28,338
-8,985
| -24% | -$1.1M | ﹤0.01% | 1186 |
|
|
2018
Q2 | $3.67M | Buy |
37,323
+17,325
| +87% | +$1.7M | ﹤0.01% | 1166 |
|
|
2018
Q1 | $1.66M | Buy |
19,998
+486
| +2% | +$40.3K | ﹤0.01% | 1541 |
|
|
2017
Q4 | $1.51M | Sell |
19,512
-20,673
| -51% | -$1.6M | ﹤0.01% | 1638 |
|
|
2017
Q3 | $2.46M | Buy |
40,185
+7,468
| +23% | +$458K | ﹤0.01% | 1359 |
|
|
2017
Q2 | $1.51M | Sell |
32,717
-21,378
| -40% | -$983K | ﹤0.01% | 1674 |
|
|
2017
Q1 | $2.34M | Sell |
54,095
-113,758
| -68% | -$4.93M | ﹤0.01% | 1306 |
|
|
2016
Q4 | $6.5M | Buy |
167,853
+145,527
| +652% | +$5.63M | 0.01% | 862 |
|
|
2016
Q3 | $1.13M | Buy |
22,326
+5,971
| +37% | +$302K | ﹤0.01% | 1810 |
|
|
2016
Q2 | $744K | Sell |
16,355
-68,548
| -81% | -$3.12M | ﹤0.01% | 1877 |
|
|
2016
Q1 | $3.36M | Buy |
84,903
+58,428
| +221% | +$2.31M | ﹤0.01% | 1055 |
|
|
2015
Q4 | $1.5M | Buy |
26,475
+8,449
| +47% | +$478K | ﹤0.01% | 1505 |
|
|
2015
Q3 | $717K | Buy |
18,026
+2,336
| +15% | +$92.9K | ﹤0.01% | 1951 |
|
|
2015
Q2 | $750K | Sell |
15,690
-2,120
| -12% | -$101K | ﹤0.01% | 1880 |
|
|
2015
Q1 | $707K | Sell |
17,810
-11,110
| -38% | -$441K | ﹤0.01% | 2017 |
|
|
2014
Q4 | $646K | Buy |
28,920
+25,678
| +792% | +$574K | ﹤0.01% | 2206 |
|
|
2014
Q3 | $50K | Sell |
3,242
-83
| -2% | -$1.28K | ﹤0.01% | 3679 |
|
|
2014
Q2 | $50K | Sell |
3,325
-15,221
| -82% | -$229K | ﹤0.01% | 3560 |
|
|
2014
Q1 | $298K | Sell |
18,546
-12,427
| -40% | -$200K | ﹤0.01% | 2521 |
|
|
2013
Q4 | $289K | Buy |
30,973
+14,077
| +83% | +$131K | ﹤0.01% | 2821 |
|
|
2013
Q3 | $191K | Buy |
16,896
+10,206
| +153% | +$115K | ﹤0.01% | 2638 |
|
|
2013
Q2 | $89K | Buy |
+6,690
| New | +$89K | ﹤0.01% | 3375 |
|